Bluejay Diagnostics, Inc., headquartered in Acton, MA, trades on Nasdaq and is seeking FDA approval for product submissions.
1 report, 1 independent
Updated Jun 6
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Bluejay Diagnostics, Inc., headquartered in Acton, MA, trades on Nasdaq and is seeking FDA approval for product submissions.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Nasdaq
American fully electronic stock exchange
- Chainlink, Nasdaq, Depository Trust & Clearing Corporation, and New York Stock Exchange are partnering on a tokenization platform for clearing services related to real-world assets and equities.
- BioPharma stock was traded on the NASDAQ stock exchange on July 30, 2026, with its performance tracked by financial blogs.
-
Acton
town in Massachusetts, United States
Related events
- Regeneron Pharmaceuticals stock is traded on the Nasdaq exchange.
- Eloxx Pharmaceuticals, Inc. began trading on the Nasdaq exchange on June 30, 2026.
- Janux Therapeutics, Inc. was listed on the Nasdaq stock exchange on July 28, 2026.
- Odyssey Therapeutics, Inc. shares are being traded on the Nasdaq exchange.
- Polar Power, headquartered in Gardena, California, is trading on the Nasdaq stock exchange.